MindWalk Holdings (HYFT) Intangibles (2020 - 2025)
MindWalk Holdings (HYFT) reported Intangibles of $749811.5 for Q2 2025, down 95.68% year-over-year from $17.4 million in Q2 2024, and down 5.3% quarter-over-quarter from $791775.8 in Q1 2025.
MindWalk Holdings (HYFT) Intangibles (2020 - 2025) Analysis & Trends
MindWalk Holdings (HYFT) has 6 years of Intangibles data on file, last reported at $749811.5 in Q2 2025.
- Intangibles for Q2 2025 came in at $749811.5, down 95.68% year-over-year; the trailing twelve-month figure through Apr 2025 was $749811.5 (down 95.68% YoY), and the FY2025 annual result was $765985.8, down 95.59% from the prior year.
- Intangibles slipped to $749811.5 in Q2 2025 per HYFT's latest filing, from $791775.8 in the prior quarter.
- Over five years, Intangibles peaked at $23.4 million in Q3 2022 and troughed at $109613.1 in Q2 2021.
- A 5-year average of $11.7 million and a median of $11.4 million in 2023 frame the typical range for Intangibles.
- The sharpest annual moves came in 2021 and 2023: Intangibles slumped 98.76% in 2021, then jumped 4113.71% in 2023.
- A 5-year view of Intangibles shows it stood at $3.9 million in 2021, then soared by 489.75% to $22.8 million in 2022, then fell by 6.38% to $21.4 million in 2023, then dropped by 21.1% to $16.8 million in 2024, then slumped by 95.55% to $749811.5 in 2025.
- Business Quant data shows HYFT's Intangibles at $749811.5 in Q2 2025, $791775.8 in Q1 2025, and $16.8 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 7.73 Mn |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2025 | 749,811.51 |
| Jan 31, 2025 | 791,775.78 |
| Oct 31, 2024 | 16.85 Mn |
| Jul 31, 2024 | 17.11 Mn |
| Apr 30, 2024 | 17.37 Mn |
| Jan 31, 2024 | 20.61 Mn |
| Oct 31, 2023 | 21.35 Mn |
| Jul 31, 2023 | 22.01 Mn |
| Apr 30, 2023 | 5.99 Mn |
| Jan 31, 2023 | 23.35 Mn |
| Oct 31, 2022 | 22.81 Mn |
| Jul 31, 2022 | 23.44 Mn |
| Apr 30, 2022 | 142,119.92 |
| Jan 31, 2022 | 3.57 Mn |
| Oct 31, 2021 | 3.87 Mn |
| Jul 31, 2021 | 4.50 Mn |
| Apr 30, 2021 | 109,613.06 |
| Jan 31, 2021 | 5.60 Mn |
| Oct 31, 2020 | 5.87 Mn |
| Apr 30, 2020 | 8.86 Mn |